Senno Therapeutics Inc.
PrivateLast Round
Seed
Apr 14, 2026
Total Funding Raised
$4.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Senno Therapeutics Inc. is a biotechnology company developing novel therapies for fatal liver failure using human iPS cell-derived liver progenitor cells and liver organoid technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Senno Therapeutics Inc. Comparables
Compare Senno Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HepaTx Corporation | 82% | |
| KanonCure Inc. | 77% | |
| HepaRegeniX GmbH | 62% |
Senno Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 14, 2026 | ||||
| Grant | Jan 22, 2026 |
Key People
Founding team and executive leadership
Senno Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Saisei Ventures | Seed |
| Mizuho Capital | Seed |
| One Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 171% MoM, reaching 1.3K.
- Apr 14, 2026
$4.7M round led by Saisei Ventures
Senno Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Senno Therapeutics Inc.'s valuation, stock price, and market status.
Is Senno Therapeutics Inc. a public or private company?
Senno Therapeutics Inc. is a private company.
What is the current stock price of Senno Therapeutics Inc.?
Senno Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Senno Therapeutics Inc. worth (valuation)?
Valuation information for Senno Therapeutics Inc. is not publicly available.
Can I buy Senno Therapeutics Inc. stock?
Senno Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Senno Therapeutics Inc.'s last funding round?
Senno Therapeutics Inc.'s most recent funding round was Seed on April 14, 2026.
Who are the main investors in Senno Therapeutics Inc.?
Key investors in Senno Therapeutics Inc. include Saisei Ventures.
Will Senno Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Senno Therapeutics Inc..
How can I track Senno Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Senno Therapeutics Inc.'s secondary market activity and sign up for updates.